Technologies

AI-Powered TIL Analysis by Lunit Unveils Prognostic Insights for Colon Cancer – published in npj Precision Oncology

  • by

​ AI-powered spatial analysis of tumor-infiltrating lymphocytes using Lunit SCOPE IO provides accurate prognosis prediction in stage II–III colon cancer SEOUL, South Korea, Nov. 27, 2023 /PRNewswire/ — Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions… Read More »AI-Powered TIL Analysis by Lunit Unveils Prognostic Insights for Colon Cancer – published in npj Precision Oncology